发明名称 |
Leukemia treatment method and composition |
摘要 |
A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay. |
申请公布号 |
US8242101(B2) |
申请公布日期 |
2012.08.14 |
申请号 |
US20100765033 |
申请日期 |
2010.04.22 |
申请人 |
BHALLA KAPIL N.;UNIVERSITY OF SOUTH FLORIDA |
发明人 |
BHALLA KAPIL N. |
分类号 |
A01N43/00;A01N43/36;A61K;A61K31/195;A61K31/33;A61K31/40 |
主分类号 |
A01N43/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|